GenScript Biotech Corporation is a global leader in providing life sciences research services and manufacturing solutions, including gene synthesis, peptide synthesis, and cell therapy.

GenScript Biotech Corporation, founded in 2002, is a leading global biotechnology company committed to advancing life sciences through cutting-edge services and products. The company offers a broad portfolio of solutions that span molecular cloning, gene synthesis, protein and antibody engineering, peptide synthesis, and cell therapy. With a focus on innovation and customer satisfaction, GenScript supports pharmaceutical, biotech, and academic sectors by providing high-quality, reliable products and services. Their comprehensive expertise and robust global network enable them to meet diverse research and development needs.

Key products and services:

• Gene synthesis
• Peptide synthesis
• Recombinant antibody and protein services
• CRISPR gene editing
• Cell therapy services
• mRNA synthesis and LNP formulation
• DNA libraries and cloning
• Protein purification and expression services
• Stable cell line development

As a trusted partner in the life sciences and biotechnology industries, GenScript continues to lead with a commitment to innovation, quality, and sustainability. Through its extensive portfolio of services and solutions, the company plays a crucial role in advancing research, drug development, and manufacturing efforts worldwide.